PinnyPeptide

P21 (P021) vs Semax

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

P21 (P021)

Cognitive

Neurogenic, anti-tau peptide derived from ciliary neurotrophic factor — Alzheimer's research.

Peptide B

Semax

Cognitive

Neuroprotective ACTH analog with nootropic and neurotrophic properties.

Typical vial

5 mg

Typical dose

Per kg dosing mcg

Half-life

Variable; designed for sustained activity

FDA status

Not FDA approved.

Typical vial

5 mg

Typical dose

200-600 mcg

Half-life

~2-3 minutes (very rapid degradation; biological effects last hours due to downstream gene expression changes)

FDA status

Not FDA approved for human use. Approved in Russia for strok…

P21 (P021) effects

  • Promotes adult hippocampal neurogenesis
  • Increases dendritic spine density
  • Reduces tau hyperphosphorylation (anti-tauopathy)
  • Improves learning and memory in Alzheimer's mouse models
  • Crosses the blood-brain barrier after peripheral administration

Semax effects

  • Upregulates BDNF and NGF expression for neuroprotection
  • Enhances memory formation, learning, and attention
  • Promotes neuronal survival after ischemic injury
  • Modulates serotonergic and dopaminergic neurotransmission
  • Supports optic nerve health and visual function

P21 (P021) side effects

  • Essentially uncharacterized in humans
  • Theoretical: off-target effects on CNTF / leptin receptor pathways
  • Possible effects on appetite and metabolism (CNTF-family signaling)
  • Injection-site reactions

Semax side effects

  • Mild nasal irritation with intranasal administration
  • Occasional headache
  • Rare anecdotal reports of hair thinning at high doses
  • Mild dizziness in sensitive individuals

P21 (P021) dosing ranges

Neurogenesis research (preclinical)

40-200 mcg/kg · Daily or alternate-day SubQ · Per research protocol

Semax dosing ranges

Cognitive enhancement

200-600 mcg · Once or twice daily (intranasal) · 10-20 days per course

Neuroprotection / stroke recovery

600-1200 mcg · Two to three times daily (intranasal) · 10-14 days

P21 (P021) vs Semax — common questions

What is the difference between P21 (P021) and Semax?

P21 (P021): Neurogenic, anti-tau peptide derived from ciliary neurotrophic factor — Alzheimer's research. Typical dose Per kg dosing mcg. Semax: Neuroprotective ACTH analog with nootropic and neurotrophic properties. Typical dose 200-600 mcg. Both fall under the Cognitive category.

Can you stack P21 (P021) and Semax?

Stacking P21 (P021) with Semax is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, P21 (P021) or Semax?

P21 (P021) is typically dosed: Daily or alternate-day SubQ for Neurogenesis research (preclinical). Semax is typically dosed: Once or twice daily (intranasal) for Cognitive enhancement; Two to three times daily (intranasal) for Neuroprotection / stroke recovery.

Are P21 (P021) and Semax FDA approved?

P21 (P021): Not FDA approved. Semax: Not FDA approved for human use. Approved in Russia for stroke recovery, cognitive impairment, and optic nerve disease.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free